Search Results 571-580 of 15622 for desimone

1. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

   Cabozantinib-s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

2. Publications - Steven J. Lester, M.D. - Mayo Clinic

   Awad K, Kamel M, Mahmoud AK, Farina JM, Badr A, Pereyra M, Scalia IG, Abbas MT, Ali NB, Alsidawi S, Lester SJ, Abu Rmilah A, Barry T, Shen WK, Srivathsan K, ...

3. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

   Cediranib maleate and selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cediranib maleate may also stop the ...

4. Surgery Physicians - Medical Professionals - Mayo Clinic

   The Department of Surgery at Mayo Clinic is dedicated to high quality patient care, education, basic science and clinical research.

5. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in subjects with moderately and ...

6. Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss - Mayo Clinic

   This study aims to demonstrate that the investigational drug AUT00063 is effective and safe in the treatment of age-related hearing loss. Participation ...

7. A Study of Poziotinib in Patients with NSCLC With EGFR or HER2 Exon 20 Insertion Mutation - Mayo Clinic

   The purpose of this study is to evaluate the efficacy and the safety/tolerability of poziotinib in patients with NSCLC exon 20 insertion mutations.

8. Faculty - Mayo Clinic Research

   The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...

9. A Study of the Characteristics and Outcomes of Treatment for C. Diff in Post-Transplant Patients - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. News - Cornelius A. Thiels, D.O., M.B.A. - Mayo Clinic

    Cornelius A. Thiels, D.O., M.B.A. · Hepatobiliary and Pancreas Surgeon · Surgical Oncologist.